Elmiron users are hiring lawyers to investigate links between the bladder pain drug and vision issues such as blurry vision and even blindness.
Elmiron is manufactured by Janssen Pharmaceutical Companies, a subsidiary of Johnson & Johnson.
In a January 2020 study, 23% of long term users of Elmiron showed signs of retinal damage. The Elmiron lawyers at Jones Ward PLC believe this was avoidable.
ELMIRON VISION LOSS
Janssen Pharmaceutical’s negligence started from the very beginning when they applied to get FDA approval for Elmiron in 1996 without citing a single study about Elmiron’s impact on retinal damage despite the fact that Janssen Pharmaceutical knew that the retina is particularly at risk for drug toxicity because of the retina’s poor ability to regenerate.
Once Elmiron’s impact on vision was discovered, Janssen was slow to correct their error. Namely, there were warnings that Elmiron was linked to vision issues as early as November 2018 when Dr. Pearce reported that long-term users of Elmiron were experiencing vision issues. In response to these warnings, Janssen Pharmaceutical changed the label of Elmiron sold in Canada to show the risk of vision loss in September 2019, but waited until June 16, 2020 to change the label in the U.S.
FREE ELMIRON LEGAL CONSULTATION
If you or a loved one consistently used Elmiron, and developed vision issues while using it, contact the pharmaceutical injury attorneys at JONES WARD PLC for a free case evaluation. We can discuss whether you have a potential claim against Janssen. Call us toll free today at 888-595-2922.
